| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695676 | Gynecologic Oncology | 2017 | 8 Pages |
Abstract
Metformin alone or in combination with MEK and glycolytic inhibitors may be a potential therapy for LGSOC, a cancer that is indolent but chemo-resistant.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ismail Mert, Jasdeep Chhina, Ghassan Allo, Jing Dai, Shelly Seward, Mark S. Carey, Marta Llaurado, Shailendra Giri, Ramandeep Rattan, Adnan R. Munkarah,